SiteCenter were delighted to be selected as the winning bidder to create a new biotechnology website for OncoImmunity AS. Our brief included developing brand assets for this early stage start-up, as well as full website design and development. As part of our solution, we created a fully bespoke secure dashboard with a Content Management System (CMS) to give the client full control over the website's content.
We were behind OncoImmunity's web strategy for over five years - from tech discovery to acquisition by NEC in 2019.